secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tracon Pharmaceuticals, Inc. (—)
CIK:        0001394319
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0000950170-23-069091
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TRACON receives Nasdaq delisting notice for non-compliance with market value and bid price rules; intends to appeal
--------------------------------------------------------------------------------

- Nasdaq determined TRACON failed to regain compliance with Market Value Rule ($35M minimum) and Minimum Bid Price ($1.00) by Dec 5, 2023 deadline.
- Suspension and delisting of common stock scheduled for Dec 15, 2023 unless TRACON appeals by Dec 13, 2023.
- Company intends to appeal before the Dec 13 deadline; appeal will stay suspension pending Hearings Panel decision.
- Hearing typically scheduled 30-45 days after request; Panel decision within 30 days of hearing. Outcome uncertain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394319/000095017023069091/0000950170-23-069091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394319/000095017023069091/tcon-20231206.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-069091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer